@article{TCR17583,
author = {Francesca Maddalena and Giacomo Lettini and Franca Esposito and Matteo Landriscina},
title = {RAD6: a new target to overcome platinum resistance in ovarian cancer?},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 9},
year = {2017},
keywords = {},
abstract = {Ovarian cancer (OC) is a deadly disease, representing the fifth leading cause of cancer death worldwide. In such a context, the major barrier to improve OC survival is resistance to chemotherapy, including platinum. Indeed, the majority of OC patients respond to initial therapy with tumor cytoreductive surgery and platinum-based chemotherapy, but approximately 70% of advanced stage patients will develop tumor recurrence and eventually succumb to recurrent disease, typically characterized by multiple drug resistance (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/17583}
}